GB2531850B - Phyto-active based anti-cancer formulation - Google Patents

Phyto-active based anti-cancer formulation

Info

Publication number
GB2531850B
GB2531850B GB1510538.0A GB201510538A GB2531850B GB 2531850 B GB2531850 B GB 2531850B GB 201510538 A GB201510538 A GB 201510538A GB 2531850 B GB2531850 B GB 2531850B
Authority
GB
United Kingdom
Prior art keywords
phyto
based anti
active based
cancer formulation
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB1510538.0A
Other versions
GB201510538D0 (en
GB2531850A (en
Inventor
Vasant Thakkar Jatin
Örn Lárusson Gísli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OMNI CURE Ltd
Original Assignee
OMNI CURE Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by OMNI CURE Ltd filed Critical OMNI CURE Ltd
Publication of GB201510538D0 publication Critical patent/GB201510538D0/en
Publication of GB2531850A publication Critical patent/GB2531850A/en
Application granted granted Critical
Publication of GB2531850B publication Critical patent/GB2531850B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
GB1510538.0A 2014-06-20 2015-06-16 Phyto-active based anti-cancer formulation Expired - Fee Related GB2531850B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2003MU2014 2014-06-20

Publications (3)

Publication Number Publication Date
GB201510538D0 GB201510538D0 (en) 2015-07-29
GB2531850A GB2531850A (en) 2016-05-04
GB2531850B true GB2531850B (en) 2017-06-28

Family

ID=54934924

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1510538.0A Expired - Fee Related GB2531850B (en) 2014-06-20 2015-06-16 Phyto-active based anti-cancer formulation

Country Status (3)

Country Link
US (1) US10537606B2 (en)
GB (1) GB2531850B (en)
WO (1) WO2015193741A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007043058A1 (en) * 2005-10-13 2007-04-19 Ganga Raju Gokaraju Process for producing enriched fractions of tetrahydroxycurcumin and tetrahydrotetrahydroxy-curcumin from the extracts of curcuma longa
WO2008120220A1 (en) * 2007-04-03 2008-10-09 Ganga Raju Gokaraju Synergistic anti-inflammatory and antioxidant dietary supplement compositions
WO2011099029A1 (en) * 2010-02-15 2011-08-18 Laila Nutraceuticals A novel boswellia low polar gum resin extract and its synergistic compositions
WO2013147340A1 (en) * 2012-03-28 2013-10-03 주식회사 한국전통의학연구소 Composition and dietary supplement for treating lung cancer, containing frankincense extract
WO2014069695A1 (en) * 2012-10-31 2014-05-08 주식회사 한국전통의학연구소 Composition for treating pancreatic cancer and functional health food containing boswellia extract

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001078783A2 (en) * 2000-04-17 2001-10-25 Hauser, Inc. Compositions comprising natural agents for treatment of cancer

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007043058A1 (en) * 2005-10-13 2007-04-19 Ganga Raju Gokaraju Process for producing enriched fractions of tetrahydroxycurcumin and tetrahydrotetrahydroxy-curcumin from the extracts of curcuma longa
WO2008120220A1 (en) * 2007-04-03 2008-10-09 Ganga Raju Gokaraju Synergistic anti-inflammatory and antioxidant dietary supplement compositions
WO2011099029A1 (en) * 2010-02-15 2011-08-18 Laila Nutraceuticals A novel boswellia low polar gum resin extract and its synergistic compositions
WO2013147340A1 (en) * 2012-03-28 2013-10-03 주식회사 한국전통의학연구소 Composition and dietary supplement for treating lung cancer, containing frankincense extract
WO2014069695A1 (en) * 2012-10-31 2014-05-08 주식회사 한국전통의학연구소 Composition for treating pancreatic cancer and functional health food containing boswellia extract

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
"Anti-tumour and antioxidant activity of natural curcuminoids", A.J. Ruby, Cancer Letters, (1995), 94(1), 79-83 *
"Chemoprevention and Therapy of Cancer by d-Limonene", P.L. Crowell & M.N. Gould, Critical Reviews in Oncogenesis, (1994), 5(1), 1-22 *
"Curcumin and cancer cells: how many ways can curry kill tumour cells selectively", J Ravindran et al, The AAPS Journal, (2009), 11(3), 495-510 *
"Curcumin synergizes with resveratrol to inhibit colon cancer", A.P.N. Majumdar et al, Nutrition and Cancer, (2009), 61(4), 544-553 *
"Resveratrol and cancer: focus on in vivo evidence", L.G. Carter et al, Endocrine-Related Cancer, (2014), 21, R209-R225 (Feb 2014) *
"Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies", B.B. Aggarwal et al, Anticancer Research, (2004), 24, 2783-2840 *
WPI Abstract Accession No 2013-Q10452 & WO 2013/147340A1 *
WPI Abstract Accession No 2014-J00960 & WO 2014/069695A1 *

Also Published As

Publication number Publication date
US10537606B2 (en) 2020-01-21
GB201510538D0 (en) 2015-07-29
WO2015193741A1 (en) 2015-12-23
GB2531850A (en) 2016-05-04
US20170196929A1 (en) 2017-07-13

Similar Documents

Publication Publication Date Title
IL248802A0 (en) Antibody formulation
GB201407934D0 (en) Formulation
HK1243638A1 (en) Methotrexate formulation
GB201514758D0 (en) Formulation
GB201408167D0 (en) Compositions
HUE052028T2 (en) Compositions
IL248835B (en) Ceritinib formulation
HUE054584T2 (en) Maropitant formulation
GB201420306D0 (en) Compositions
GB201407384D0 (en) Formulation
IL251362A0 (en) Formulation
GB201521771D0 (en) Formulation
GB201511301D0 (en) Formulation
GB201511255D0 (en) Formulation
GB201509891D0 (en) Formulation
GB201402448D0 (en) Novel formulation
GB2531850B (en) Phyto-active based anti-cancer formulation
GB201416536D0 (en) Formulation
GB201416274D0 (en) Formulation
GB201412754D0 (en) Formulation
GB201514014D0 (en) Formulation
GB201404773D0 (en) Formulation
GB201504662D0 (en) Formulation
GB201419849D0 (en) Compositions
GB201410184D0 (en) Odontalgic preparation

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20220616